NHS Sets Two-Year Wait for ADHD & Autism Assessments

NHS Enforces Two-Year Minimum Wait for ADHD and Autism Assessments

Four NHS bodies responsible for commissioning health services across large parts of England have formally adopted a policy requiring people suspected of having ADHD or autism to wait a minimum of two years before they can access an assessment. The move, which applies to NHS integrated care boards — the regional organisations established in 2022 to plan and fund local health services — marks a significant shift from a system already under severe strain to one that has effectively institutionalised delay as standard policy.

NHS ADHD autism waiting times were already among the longest for any non-emergency condition in England before this development. The decision by four integrated care boards (ICBs) to enshrine a two-year floor is not a temporary emergency measure framed as exceptional; it is an acknowledgement that demand has outpaced capacity to such a degree that no near-term resolution is visible. For the hundreds of thousands of people currently seeking answers about their own cognition, behaviour, or mental health, that acknowledgement carries profound consequences.

An integrated care board, for those unfamiliar with NHS structures, is the statutory body that replaced clinical commissioning groups in July 2022. Each ICB is responsible for planning and funding most NHS services — including mental health and neurodevelopmental assessments — within a defined geographic footprint. When four of these organisations formally set a two-year minimum wait, they are collectively speaking for populations spanning millions of people.

Why Demand for Neurodiversity Assessments Has Surged

The surge in people seeking ADHD and autism diagnoses is one of the defining healthcare stories of this decade. Referral volumes to neurodevelopmental services in England have climbed sharply over successive years, driven by a convergence of factors that clinicians and researchers have been tracking carefully.

Greater public awareness — much of it generated through social media, particularly among adults who grew up without a diagnosis — has prompted a generation of people to connect their lived experiences to neurodivergent traits for the first time. Women and girls, historically underdiagnosed because ADHD and autism research was conducted predominantly on male subjects, are now seeking assessment in significantly larger numbers. The post-pandemic period accelerated this, as the disruption to routine and the removal of social scaffolding made previously masked traits more visible and their impact more acute.

NHS Digital data has documented the scale of this shift, with neurodevelopmental referrals rising year on year to levels that existing clinical capacity was never configured to absorb. The workforce required to conduct these assessments — clinical psychologists, consultant psychiatrists, specialist nurses — takes years to train. There is no short-term lever that resolves a gap of this magnitude.

What a Two-Year Wait Means for Patients

A two-year wait is not an abstraction. For a child struggling to regulate attention in a classroom, it represents two full academic years without formal support or an education, health and care plan underpinned by a diagnosis. For an adult who cannot hold down employment because unmanaged executive dysfunction repeatedly costs them their job, it is two years of financial precarity and eroding self-worth. For a teenager whose anxiety has escalated to crisis point because they have no framework to understand how their mind works, it can mean two years of deteriorating mental health.

The Royal College of Psychiatrists has been explicit in published guidance about the clinical risks of prolonged undiagnosed ADHD. Untreated ADHD is associated with elevated rates of anxiety, depression, substance misuse, and relationship breakdown. Children with unidentified autism are at heightened risk of school exclusion, social isolation, and the development of secondary mental health conditions that can persist into adulthood. These are not hypothetical harms that might materialise in exceptional cases. They are documented patterns that clinicians observe routinely.

A two-year wait, moreover, is a minimum. Many people will wait considerably longer once administrative delays, missed appointments, and stretched clinical teams are factored into the real-world timeline. The NHS ADHD autism waiting times that patients experience in practice have, in many regions, already stretched well beyond the two-year marker that ICBs are now treating as a baseline.

Patient Groups and Advocates Respond to 'Scandalous' Delays

Patient advocacy organisations have not accepted this development quietly. The word "scandalous" has entered the conversation explicitly, reflecting a level of moral indignation that goes beyond the usual measured language of sector responses to NHS pressures.

Organisations including ADHD UK and the National Autistic Society have long documented the harm caused by extended delays to diagnosis, and both have been vocal about the inadequacy of current investment in neurodevelopmental services. Their position, consistent with what they have argued for years, is that diagnosis is not a luxury or a bureaucratic formality — it is the gateway to appropriate support, medication, therapeutic interventions, and legal protections under the Equality Act 2010.

The formalisation of a two-year minimum by NHS bodies transforms what was previously a crisis into policy. For advocacy groups, that distinction matters. A crisis is something to be resolved. A policy is something to be challenged, overturned, or funded differently. The framing of "scandalous" reflects precisely that shift — from expressing concern about a system under pressure to expressing outrage at one that has redefined inadequacy as an acceptable norm.

The Funding Crisis Behind NHS Neurodiversity Services

The ICBs that have adopted this approach have been transparent about the driving factor: cost. They cannot afford the number of assessments that people are requesting. This is a statement about resource allocation, not clinical need. The demand is real, the need is real, and the capacity is insufficient.

Neurodevelopmental assessments are resource-intensive. A comprehensive ADHD or autism assessment typically involves multiple appointments with qualified clinicians, structured observation, cognitive testing, and collateral information from schools or workplaces. The clinician time required cannot be easily automated or compressed without compromising the quality of the assessment itself — and low-quality assessments that lead to incorrect diagnoses create their own downstream costs.

The funding challenge sits within a broader NHS financial context in which integrated care boards are managing significant budgetary pressures across all services simultaneously. Neurodevelopmental services compete for resource against urgent physical health care, mental health crisis services, and everything else an ICB is statutorily required to provide. Within that context, the decision to manage demand through extended waiting times rather than emergency investment reflects a calculation about what can realistically be funded — not a judgment that these patients matter less.

What Can People Do While Waiting for an NHS Assessment?

A two-year NHS referral period does not mean two years of inaction. There are concrete steps people can take to support themselves or their children while waiting.

First, maintaining detailed records of symptoms, their frequency, and their impact across different settings — home, school, work — creates a clinical picture that will be valuable when assessment eventually takes place. General practitioners can provide referrals for co-occurring conditions such as anxiety or depression that may be addressable in the interim.

Second, many local authorities maintain special educational needs and disability (SEND) support structures that can be accessed without a formal diagnosis. Schools can provide reasonable adjustments under existing statutory duties, and families can request an education, health and care needs assessment through their local authority independently of NHS diagnostic timelines.

Third, patient organisations such as ADHD UK and the National Autistic Society provide information, peer support communities, and practical guidance for people navigating the assessment process and managing daily life while undiagnosed. These are not replacements for clinical support, but they are substantive resources.

Finally, private assessment remains an option for those who can afford it, though costs are significant and not universally accessible. Some employers offer occupational health assessments that can provide useful documentation. The growing private market in neurodevelopmental assessment has its own quality variation concerns, but accredited practitioners working within established clinical frameworks offer a pathway for those who cannot wait two years for an NHS appointment.

The NHS ADHD autism waiting times crisis is a structural problem that requires structural solutions: sustained investment, workforce expansion, and a commissioning model that matches resource to documented need. Until that investment materialises, the burden falls disproportionately on the patients least equipped to carry it.

Source: Society | The Guardian